Goldman Sachs’s Argos Therapeutics, Inc. ARGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-5,509
| Closed | -$40K | – | 4601 |
|
|
2017
Q2 | $40K | Buy |
+5,509
| New | +$40K | ﹤0.01% | 4272 |
|
|
2017
Q1 | – | Sell |
-670
| Closed | -$66K | – | 4693 |
|
|
2016
Q4 | $66K | Sell |
670
-688
| -51% | -$67.8K | ﹤0.01% | 4193 |
|
|
2016
Q3 | $135K | Buy |
1,358
+1,198
| +749% | +$119K | ﹤0.01% | 4088 |
|
|
2016
Q2 | $20K | Buy |
+160
| New | +$20K | ﹤0.01% | 4413 |
|